Evidence map›Paper›PMID 41545855›Full record

ReviewJournal of translational medicine2026

Mitochondrial transfer: a Janus-faced force in health and disease.

Yuan Hu, Wenqin Zhou, Lin Chen

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuan HuDepartment of Anesthesia Nursing, West China Second University Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Wenqin ZhouKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, 610041, China. zhoutry@qq.com.
Lin ChenKey Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, 610041, China. chenlin2218@163.com.

Funding

National Natural Science Foundation of China 82505591
6 · The paper itself

Abstract

Mitochondrial transfer is increasingly recognized as a dynamic form of intercellular communication that reshapes how we understand tissue homeostasis, immune function, and disease progression. Rather than being a passive event, mitochondrial transfer involves the movement of organelles between cells through defined mechanisms, such as tunneling nanotubes, extracellular vesicles, or direct engulfment, altering the metabolic, epigenetic, and immunological profiles of recipient cells. In physiological and regenerative contexts, mitochondrial transfer contributes to cellular rescue, stem cell function, and organ recovery. However, in malignancies and infections, it can subvert immune surveillance, promote metabolic reprogramming, and reinforce pathological resilience. This dual capacity - simultaneously protective and pathogenic - positions mitochondrial transfer as a central yet ambivalent mechanism in health and disease. Beyond mechanistic insight, we explore its implications for emerging mitochondrial therapies, highlighting critical considerations in donor-recipient compatibility, organelle identity, and translational ethics. Mitochondrial transfer is increasingly recognized as a biologically significant process with both therapeutic potential and complex implications for our understanding of intercellular communication.

Indexed as

DiseaseHealthMitochondriaAnimalsCell CommunicationHumansImmune evasionInfectionsIntercellular communicationMitochondrial transferOrganelle therapyTumor microenvironment

Identifiers

PMID41545855
PMCPMC12810007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.